NCT07101796

Brief Summary

This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

11 months

First QC Date

December 22, 2024

Last Update Submit

July 28, 2025

Conditions

Keywords

Obstructive sleep apneapersonalitypatient complianceAnxietydepressionContinuous Positive Airway Pressure (CPAP)

Outcome Measures

Primary Outcomes (1)

  • Eysenck Personality Questionnaire (EPQ)

    This study adopted the classic short form of the Eysenck Personality Questionnaire - Revised (EPQ-R Short Scale) to assess individual personality traits across four dimensions: Psychoticism (P), Extraversion (E), Neuroticism (N), and Lie Scale (L). Each dimension consists of 12 items, with scores ranging from 0 to 12. Higher scores indicate a stronger presence of the corresponding trait. For example, a higher score on Neuroticism reflects greater emotional instability, while a higher score on Extraversion suggests a more outgoing and active personality

    At baseline

Secondary Outcomes (1)

  • continuous positive airway pressure (CPAP) compliance

    From CPAP initiation to the 3-month follow-up

Study Arms (2)

Obstructive sleep apnea (OSA)

dignosis OSA according to the sleep study (AHI\>=5)

Device: continous positive airway pressure (CPAP)

non-OSA

dignosis OSA according to the sleep study (AHI \<5)

Interventions

using CPAP to treat OSA

Obstructive sleep apnea (OSA)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Patients with sleep disorders other than sleep disorders and respiratory disorders; * Patients with severe mental diseases (such as schizophrenia, bipolar disorder, paranoid mental disorders, mental retardation associated with mental disorders, mental disorders caused by epilepsy, schizoaffective disorders) and personality disorders; * Patients who are taking sleep-affecting medication. ④ Unable to cooperate with the relevant psychological scales for depression, anxiety, personality, and others. ⑤ Patients who have previously used or are being treated with a non-invasive ventilator. ⑥ Other serious somatic diseases or other conditions that may affect ventilator treatment are unsuitable for enrollment as assessed by the investigator.

You may qualify if:

  • Age: 18\~70 years old
  • Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration.
  • Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently;
  • The patients gave informed consent to the study and cooperated with relevant treatment and evaluation.

You may not qualify if:

  • Age below 18 or above 70 years old
  • No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA
  • lacking full independence in behavior and cognitive ability, unable to answer questions independently
  • Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Respiratory Department of Peking University First Hospital

Beijing, Beijing Municipality, 10034, China

RECRUITING

MeSH Terms

Conditions

Patient ComplianceAnxiety DisordersDepressionSleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehaviorMental DisordersBehavioral SymptomsSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Jing Ma

    Peking University First Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator,

Study Record Dates

First Submitted

December 22, 2024

First Posted

August 3, 2025

Study Start

September 14, 2024

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

August 3, 2025

Record last verified: 2025-07

Locations